Centre for Sami Health Research, Department of Community Medicine, UiT the Arctic University of Norway, Tromsø, Norway.
Department of Public Health and Nursing, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Int J Circumpolar Health. 2023 Dec;82(1):2241202. doi: 10.1080/22423982.2023.2241202.
This study is the first to investigate the prevalence of filled opioid prescriptions among indigenous Sami people with self-reported chronic musculoskeletal pain (CMSP) and compare it with that of non-Sami living in the same area. Baseline data from the SAMINOR 2 Questionnaire Survey (2012) was linked prospectively to the Norwegian Prescription Database. Information on filled opioid prescriptions during 2012-2019 was collected for 4767 persons who reported CMSP in SAMINOR 2. Gender-stratified chi-square tests, two-sample -tests, Kruskal - Wallis tests, and multinomial logistic regression was applied. Two out of three CMSP respondents received no or only one prescription of opioids during 2012-2019. In each year, 80% of women received no opioids, 7-10% received one prescription of ≤ 180 defined daily doses (DDD), 8-9% received in total ≤ 180 DDD in two or more prescriptions, and 2-3% received > 180 DDD of opioids. Among men, 81-83% received no opioids, 8-11% received one prescription with ≤ 180 DDD, 5-9% received ≤ 180 DDD in two or more prescriptions, and 1-2% received > 180 DDD of opioids in a single year. There were no overall ethnic differences, which indicates a similar prescription policy for opioids for Sami and non-Sami with CMSP.
本研究首次调查了有自我报告的慢性肌肉骨骼疼痛（CMSP）的土著萨米人群中填充阿片类药物处方的流行率，并将其与居住在同一地区的非萨米人进行了比较。2012 年 SAMINOR 2 问卷调查的基线数据被前瞻性地与挪威处方数据库相链接。为报告了 SAMINOR 2 中 CMSP 的 4767 人收集了 2012-2019 年期间阿片类药物填充处方的信息。应用了性别分层卡方检验、两样本 t 检验、Kruskal-Wallis 检验和多项逻辑回归。在 2012-2019 年期间，三分之二的 CMSP 受访者没有或仅收到一份阿片类药物处方。在每年，80%的女性没有接受阿片类药物，7-10%的女性接受了一次处方，处方量为≤180 个定义日剂量（DDD），8-9%的女性总共接受了两次或更多次处方，处方量为≤180 DDD，2-3%的女性接受了处方量>180 DDD 的阿片类药物。在男性中，81-83%的男性没有接受阿片类药物，8-11%的男性接受了一次处方，处方量为≤180 DDD，5-9%的男性接受了两次或更多次处方，处方量为≤180 DDD，1-2%的男性在一年内接受了处方量>180 DDD 的阿片类药物。没有总体的种族差异，这表明对于有 CMSP 的萨米人和非萨米人，阿片类药物的处方政策相似。
